Therabel Pharma SA/NV   Report issue

For profit Phase 4
Founded: Breda Netherlands (1945)
Status: No NME R&D (1945)

Organization Overview

First Clinical Trial
2011
NCT01363661
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Therabel Pharma SA/NV

Active Ingredients

Drugs in Phase 4 Trials (1)

Molsidomine (motazomin) (1 trial)

Drugs in Other Trials (1)

saccharomyces boulardii (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Atherosclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2